Global Brain Implants Market Set for Explosive Growth, Projected to Reach USD 18 Billion by 2032

Posted on 2024-09-11 by Future Market Insights in Healthcare // 0 Comments

The global brain implants market is on the brink of extraordinary expansion, with estimates forecasting the market to reach a staggering USD 18 billion by 2032. This remarkable growth trajectory, driven by a robust compound annual growth rate (CAGR) of 12.3%, highlights the increasing demand for innovative medical solutions that address critical neurological conditions.

In 2022, the brain implants market was valued at over USD 5.7 billion, and its rapid expansion is fueled by several key factors. One of the most significant drivers is the rising incidence of nervous system cancers. According to GLOBOCAN 2020 data, there were approximately 308,102 new cases of brain and nervous system cancers worldwide in 2020. This alarming statistic, coupled with the aging population in developed nations, underscores the urgent need for advanced medical interventions, particularly in the field of brain implants.

Additionally, the market’s growth is being propelled by cutting-edge technologies tailored to meet individual patient needs. As healthcare providers prioritize improving treatment efficacy and patient outcomes, innovative brain implant solutions are becoming indispensable.

The prevalence of conditions such as trauma, malignant tumors, and congenital deformities further emphasizes the need for advanced brain implants. The medical community’s increasing focus on personalized care and technology-driven solutions is expected to play a pivotal role in shaping the future of the market.

“We are witnessing a transformative phase in the brain implants market,” stated a representative from FMI. “The convergence of rising cancer cases, an aging population, and technological advancements is setting the stage for unprecedented growth in this sector.”

There are several factors that are propelling the demand for brain implants:

Rising neurological disorders: As the population ages, there’s a growing need for treatment options for conditions like Parkinson’s disease, epilepsy, and depression. Brain implants offer a potential long-term solution for these patients when medication proves ineffective.
Mental health needs: Conditions like stress and obesity-related depression are becoming more prevalent. Brain implant technologies are being explored as a possible treatment option for these conditions.
Technological advancements: MRI and new technologies like deep brain stimulation are making brain implant surgery more precise and effective. This is leading to more patients being considered as candidates for this type of treatment.
Improved mobility: Technologies like motor neuron prostheses, Brain Computer Interfaces (BCI), and micro electrode arrays are being used to help patients with mobility issues. These advancements are increasing the potential applications of brain implants.

Overall, the demand for brain implants is being driven by a combination of factors, including the growing need for treatment options for neurological and mental health conditions, along with the development of new and more sophisticated technologies.

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Competitive Analysis:

Market players are continually advancing analytical solutions and broadening their product offerings. Companies in the brain implants market are concentrating on strategic alliances, technology collaborations, and product launch initiatives. Tier 2 players in the market are aiming to increase their share of the brain implant market.

Recent developments from key neural implant providers include:

In April 2022, the FDA approved brain stimulation software for use in Parkinson’s disease. The Vercise Neural Navigator with Stimview XT enables clinicians to visualize lead placement and stimulation modeling, offering patient-specific 3D modeling for tailored therapy. This software is designed to aid in lead placement, reduce programming time, and enhance treatment decisions.
In June 2021, Medtronic plc received FDA approval for its SenSight Directional Lead System, used in deep brain stimulation therapy.

Key Companies Profiled:

Abbott Laboratories
Medtronic PLC
NeuroPace Incorporation
Nevro Corporation
Aleva Neurotherapeutics SA
Synapse Biomedical Incorporation
Boston Scientific Corporation
Sapiens Neuro
Edwards Lifesciences Corporation

Brain Implants Market Segmentation:

By Product Type:

Deep Brain Stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator

By Application:

Brain Implant for Chronic Pain
Brain Implant for Epilepsy
Deep Brain Simulation for Parkinson’s Disease
Brain Implant for Depression
Brain Implant for Essential tremor
Brain Implant for Alzheimer’s Disease

By Region:

North America
Latin America
Europe
APAC
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick